Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

The use of abacavir (ABC) has been associated with an increased risk of cardiovascular disease in some cohort studies. However, no excess risk of myocardial infarction (MI) with ABC therapy has been observed in individual randomized clinical trials (RCTs) and in the aggregated clinical trials databa...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	AIDS (London) Ročník 25; číslo 16; s. 1993
Hlavní autori:	Cruciani, Mario, Zanichelli, Veronica, Serpelloni, Giovanni, Bosco, Oliviero, Malena, Marina, Mazzi, Romualdo, Mengoli, Carlo, Parisi, Saverio G, Moyle, Graeme
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 23.10.2011
Predmet:	Anti-HIV Agents - administration & dosage Anti-HIV Agents - adverse effects Cardiovascular Diseases - chemically induced Cardiovascular Diseases - mortality Dideoxynucleosides - administration & dosage Dideoxynucleosides - adverse effects Female HIV Infections - drug therapy HIV Infections - mortality Humans Male Myocardial Infarction - chemically induced Myocardial Infarction - mortality Odds Ratio Randomized Controlled Trials as Topic Risk Factors
ISSN:	1473-5571, 1473-5571
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!